Literature DB >> 25337231

Grandinin down-regulates phosphorylation of epidermal growth factor receptor.

Zhuling Qu1, Aiqin Song1, Wei Feng1, Ruyang Teng1, Jie Gao1, Xuanlong Yi1.   

Abstract

AIMS: Grandinin (C(46)H(34)O(30)) is a compound found in Melaleuca quinquenervia leaves and in oaks. This study is to determine effects of grandinin on malignant lung cells and the related molecular mechanisms.
METHODS: Malignant cells were treated with grandinin with various concentrations. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrozolium bromide (MTT) assays and apoptosis assays were performed to determine effects of grandinin on cell viability and apoptosis. Western blotting and real time-PCR were used to determine if grandinin affects levels of phosphorylated EGFR (p-EGFR) and phosphorylated AKT (p-AKT), as well as their mRNA transcript levels.
RESULTS: It was found that grandinin treatments reduce viability of malignant lung cells and induces apoptosis. When treated with grandinin (16 μM), the apoptosis of the three lung cancer cell lines MS-1, A549, and LK-2 were increased by 8-9 folds, in comparison with the cells treated with DMSO only (the control condition). Furthermore, grandinin treatments lead to down-regulation of levels of p-EGFR and p-AKT in three malignant lung cell lines. However, grandinin does not affect mRNA levels of EGFR and AKT.
CONCLUSIONS: These experimental results indicated grandinin significantly reduce malignant cell viability and effectively induces apoptosis of malignant lung cells by mediating phosphorylation down-regulation of cellular signaling proteins EGFR and AKT. It is suggested that grandinin treatments might be an effective therapeutic strategy of lung malignancies upon further studies in the future.

Entities:  

Keywords:  Grandinin; down-regulates phosphorylation; epidermal growth factor receptor; phosphorylation

Mesh:

Substances:

Year:  2014        PMID: 25337231      PMCID: PMC4203202     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  28 in total

Review 1.  Oncogenic pathways, molecularly targeted therapies, and highlighted clinical trials in non-small-cell lung cancer (NSCLC).

Authors:  Thanyanan Reungwetwattana; Saravut J Weroha; Julian R Molina
Journal:  Clin Lung Cancer       Date:  2011-12-08       Impact factor: 4.785

2.  The substitution pattern of anthocyanidins affects different cellular signaling cascades regulating cell proliferation.

Authors:  Doris Marko; Nicole Puppel; Zeina Tjaden; Sandra Jakobs; Gudrun Pahlke
Journal:  Mol Nutr Food Res       Date:  2004-09       Impact factor: 5.914

3.  Expression of phosphorylated Akt in patients with small cell carcinoma of the lung indicates good prognosis.

Authors:  Satoshi Ikeda; Kazuhiko Takabe; Masaharu Inagaki; Keiko Suzuki
Journal:  Pathol Int       Date:  2010-10-06       Impact factor: 2.534

4.  Interaction of radiation and gefitinib on a human lung cancer cell line with mutant EGFR gene in vitro.

Authors:  Yumi Sato; Takeshi Ebara; Noriaki Sunaga; Takeo Takahashi; Takashi Nakano
Journal:  Anticancer Res       Date:  2012-11       Impact factor: 2.480

5.  Polyphenols of Melaleuca quinquenervia leaves--pharmacological studies of grandinin.

Authors:  F A Moharram; M S Marzouk; S A A El-Toumy; A A E Ahmed; E A Aboutabl
Journal:  Phytother Res       Date:  2003-08       Impact factor: 5.878

6.  Autophosphorylation sites on the epidermal growth factor receptor.

Authors:  J Downward; P Parker; M D Waterfield
Journal:  Nature       Date:  1984 Oct 4-10       Impact factor: 49.962

7.  Anticancer and antioxidant tannins from Pimenta dioica leaves.

Authors:  Mohamed S A Marzouk; Fatma A Moharram; Mona A Mohamed; Amira M Gamal-Eldeen; Elsayed A Aboutabl
Journal:  Z Naturforsch C J Biosci       Date:  2007 Jul-Aug

8.  Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases.

Authors:  Jerome F Sah; Sivaprakasam Balasubramanian; Richard L Eckert; Ellen A Rorke
Journal:  J Biol Chem       Date:  2003-12-29       Impact factor: 5.157

Review 9.  The potential role of Akt phosphorylation in human cancers.

Authors:  J Cicenas
Journal:  Int J Biol Markers       Date:  2008 Jan-Mar       Impact factor: 3.248

10.  Combined effects of 17-DMAG and TNF on cells through a mechanism related to the NF-kappaB pathway.

Authors:  Zhuling Qu; He Dong; Xiaolin Xu; Wei Feng; Xuanlong Yi
Journal:  Diagn Pathol       Date:  2013-05-01       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.